Skip to main content

Table 4 HSU weights by subgroup

From: Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review

 

Utility Value

(SD)

Sample Size (N)

Instrument

Country

Source

CKD Stage 2

 

0.85 (95% CI: 0.70–1)

29

EQ-5D-3L

UK

[16]

CKD Stage 3

 Stage 3a

0.80 (95% CI: 0.69–1)

45

EQ-5D-3L

UK

[16]

 Stage 3b

0.80 (95% CI: 0.68–1)

173

EQ-5D-3L

UK

[16]

 Stage 3

0.67 (0.31)

50

HUI3

USA

[17]

CKD Stage 4

0.74 (95% CI: 0.62–0.85)

423

EQ-5D-3L

USA

[16]

0.55 (0.34)

65

HUI3

USA

[17]

CKD Stage 5

0.54 (0.36)

28

HUI3

USA

[17]

0.73 (95% CI: 0.62–1)

75

EQ-5D-3L

UK

[16]

Haemodialysis

0.75 (0.25)

1767

EQ-5D-3L

Various

[18]

0.44 (0.32)

99

EQ-5D-3L

UK

[19]

0.78 (0.24)

200

EQ-5D-3L

Various

[20]

0.60 (95% CI: 0.55, 0.64)

128

EQ-5D-3L

Canada

[21]

0.69 (95% CI: 0.63,0.76)

51

EQ-5D-3L

Canada

[22]

0.54 (0.31)

271

HUI3

USA

[17]

0.75 (0.11)

315

SF-6D

China

[23]

0.73 (0.11)

135

SF-6D

China

[24]

0.78 (0.09)

41

SF-6D

China

[24]

0.79 (0.11)

118

SF-6D

China

[24]

Peritoneal Dialysis

0.53 (0.34)

64

EQ-5D-3L

UK

[19]

0.78 (0.11)

103

SF-6D

China

[24]

Unspecified Dialysis

0.54 (0.31)

38

HUI3

USA

[17]

0.74 (0.20)

185

HUI2

Canada

[25]

0.58 (0.26)

185

HUI3

Canada

[25]

0.67 (0.13)

185

SF-6D

Canada

[26]

Pre-Transplant

NR

    

Post-Transplant

 CKD stage 1–2

0.79 (0.25)

386

HUI3

USA

[27]

 CKD stage 3

0.87 (0.14)

172

EQ-5D-3L

USA

[27]

 CKD stage 3

0.75 (0.26)

172

HUI3

USA

[27]

 CKD stage 4

0.87 (0.10)

51

EQ-5D-3L

USA

[27]

 CKD stage 4

0.74 (0.22)

51

HUI3

USA

[27]

 CKD stage 5

0.82 (0.12)

19

EQ-5D-3L

USA

[27]

 CKD stage 5

0.67 (0.33)

19

HUI3

USA

[27]

 CKD stage not reported

0.71 (0.27)

209

EQ-5D-3L

UK

[19]

 CKD stage not reported

0.77 (NR)

126

SF-6D

Spain

[28]

 CKD stage not reported

0.76 (NR)

80

SF-6D

Spain

[28]

  1. Abbreviations: CKD chronic kidney disease, HUI2 Health Utilities Index Mark 2, HUI3 Health Utilities Index Mark 3, NR not reported, RRT renal replacement therapy, SD standard deviation, SF-6D Short Form questionnaire-6 Dimensions